Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing to give written consent to take part in the study voluntarily.
- You must agree to follow all study steps, including attending all follow-up appointments.
- You have a thyroid nodule that has been tested and placed in a category called "Bethesda VI," the nodule is no larger than 1.5 cm, and there is no known spread to other areas.
- You have a thyroid nodule in a category called "Bethesda V" and your calcitonin levels (a specific blood marker) are normal.
- An ultrasound scan of the nodule to be treated must show it is 1.5 cm or smaller, has not grown outside the thyroid, and there is no sign of spread to nearby areas.
- Your blood count, blood clotting, and thyroid function tests must all come back as normal.
- If you are a woman who could become pregnant, you must have a negative pregnancy test before the procedure begins.
- Women who could become pregnant and men taking part must agree to use an approved form of birth control throughout the study (confirm with trial site for the full list of accepted methods).
- Men must also agree to use contraception for at least 4 months after the study procedure is completed.
Who may not be able to join:
- Your biopsy results suggest a more aggressive or high-grade form of cancer.
- There is evidence that the cancer has spread to nearby lymph nodes or other parts of the body.
- You have previously had radiation treatment to your neck area.
- You are pregnant at the time of enrollment.
- You have any other health condition or situation that the study doctor feels could put you at significant risk, affect the study results, or prevent you from fully participating (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Victoria E Banuchi, MPH, M.D. Anderson Cancer Center
Phone: 713-563-7600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.